Malaysia Reports First COVID-19 Death In 2025
GENERAL
PUTRAJAYA, June 19 (Bernama) -- Malaysia recorded its first COVID-19-related death of the year during Epidemiological Week 24 (ME24), according to the Health Ministry (MOH).
The fatality involved a patient with serious comorbidities, including heart disease and diabetes, who had not received a second booster dose.
'This marks a significant decline compared to 57 COVID-19 deaths reported in 2024, with the last fatality recorded on May 26 last year,' it said in a statement today.
The decline, it added, reflects the effectiveness of ongoing control measures. However, COVID-19 cases rose to 3,379 during ME24, up from 2,011 cases the previous week.
Despite the increase, the national situation remains under control and below the alert threshold, due to ongoing surveillance and public health interventions.
To date, a total of 21,738 cases have been reported this year, with the weekly average holding steady at around 900.
Six patients were admitted to intensive care during ME24, all with underlying health conditions such as hypertension, diabetes, heart disease and Down syndrome.
All received intensive care, with four discharged home and two transferred to general wards.
MOH continues to encourage all Malaysians, from unborn babies to the elderly, to stay protected by following appropriate vaccination schedules under the National Immunisation Programme.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Herald Malaysia
an hour ago
- Herald Malaysia
More Palestinians killed in new wave of Gaza strikes
At least 81 Palestinians were killed in Israeli airstrikes across Gaza over a 24-hour period, according to Gaza health officials, as Israeli forces targeted areas where displaced civilians were sheltering. Jun 30, 2025 Mourners react near the body of a Palestinian child killed in an Israeli strike, in Gaza City By Nathan MorleyAt least 81 Palestinians were killed in Israeli airstrikes across Gaza over a 24-hour period, according to Gaza health officials, as Israeli forces targeted areas where displaced civilians were sheltering. The strikes hit a tent camp near a stadium in Gaza City and a school in the Tuffah neighbourhood, authorities said. Among the dead were children and entire families. Gaza's Health Ministry said more than 56,400 Palestinians have been killed since the war began in October 2023. The surge in casualties has intensified international calls for a ceasefire, with diplomatic efforts reportedly ongoing involving U.S. and Qatari mediators. The Israeli military earlier said it had killed one of the founding members of Hamas. Israel resumed large-scale military operations in Gaza in early March. Since then, at least 6,050 Palestinians have been killed and more than 21,000 wounded, bringing the total number of injuries since the beginning of the war to over 133,000, according to Gaza-based officials. Iran uranium enrichment programme In a separate development, the head of the U.N. nuclear watchdog said Iran could resume uranium enrichment within months. International Atomic Energy Agency Director General Rafael Grossi said last week's airstrikes damaged nuclear infrastructure but did not cause total destruction. Grossi's comments appeared to contradict U.S. claims that Iran's nuclear capabilities had been significantly set back.--Vatican News
The Star
5 hours ago
- The Star
Here's the AI diagnosis: How the tech is being leveraged in M'sia's public healthcare system
A man in his 60s showed up for a routine health screening at a private hospital in Klang Valley last year. Despite being a smoker, he wasn't displaying any symptoms that might have indicated a health issue. On that day, he also underwent a chest X-ray augmented by artificial intelligence (AI) software, which was designed to detect subtle abnormalities that the human eye may sometimes overlook. Prof Anand Sachithanandan, a consultant cardiothoracic surgeon, recalls how the software detected a small shadow in the upper zone of the man's left lung. 'It was something that would most likely be easily missed or overlooked by conventional X-ray imaging,' he says in a statement to LifestyleTech. Prof Anand adds that further investigations revealed an elevated tumour marker, which could be a sign of cancer in the body. While this may sound alarming, additional tests are needed to confirm the diagnosis. 'He was swiftly investigated with CT thorax scan, PET scan and biopsy – confirming an early-stage primary lung cancer,' he says. Prof Anand adds that they performed a surgery to resect (remove) the tumour. Three days later, the man recovered well and went home. AI has the potential to sift through voluminous data very quickly and will pave the way for precision diagnostics and personalised treatments in the future. — Prof Anand Sachithanandan It was the first known case of AI helping to detect lung cancer in Malaysia, where Prof Anand says the technology involved cloud-based software powered by deep learning algorithms. 'The case demonstrated the potential to screen for lung cancer with a chest X-ray and how the technology can aid radiologists. 'It also highlighted the quick turnaround time which contributed in part to the patient completing definitive treatment in less than two weeks,' he adds. AI and early detection Malaysia began incorporating AI screening as early as 2020, when private healthcare centres launched initiatives to use AI for detection of retinal diseases. The adoption of AI is now broadening to public healthcare with the Health Ministry driving initiatives to use AI to detect diseases. Last year, the Health Ministry announced the roll-out of Dr Mata, an AI-driven software solution to detect and diagnose diabetic retinopathy, an eye disease caused by diabetes, in a pilot project involving around 140 government clinics. According to Health Ministry deputy director-general for research and technical support Datuk Dr Nor Fariza Ngah in a report, the technology can help to produce eye test results at a faster rate and would lead to better outcomes for patients. Then in May, the Health Ministry announced that an AI-powered lung cancer screening initiative will be rolled out at seven health clinics nationwide – including in Kelantan, Pahang, and Kedah – starting this year. 'With this AI capability, the incident detection rate is significantly improved,' Bernama quoted Health Minister Datuk Seri Dr Dzulkefly Ahmad as saying during a National Lung Health Initiative 2025-2030 briefing in May. Based on the latest available National Cancer Registry Report (2017-2021), Prof Anand says lung cancer remains one of the leading cancers in Malaysia, with reported cases on the rise: 'It now makes up 10% of all cancer cases, ranks as the second most common cancer among men, and is the third most common among women.' He adds that the Health Ministry's initiative to prioritise lung cancer screening is timely, as identifying the disease at an earlier stage offers a significantly better chance of successful treatment. 'As the Health Ministry remains the largest healthcare service provider, adoption of AI-enabling screening in government clinics has the potential to create a significant impact in terms of meaningful stage shift to detect more cases at an early-stage when the cancer is more amenable to curative-intent treatments like surgery,' he adds. While AI can be scaled and deployed in rural areas to assist clinic staff without a radiologist or doctor on-site, Prof Anand points out that strong communication networks are essential for it to work effectively. — Image by freepik Prof Yeong Chai Hong from the School of Medicine, Faculty of Health & Medical Sciences, Taylor's University, says AI-driven diagnostics screening at government clinics reflects the country's agenda of moving towards preventive data-driven healthcare. 'The efforts can also be seen as an attempt to demonstrate Malaysia's commitment towards bridging the healthcare gap between urban and rural communities through scalable, data-driven solutions. 'It signals a shift from reactive to proactive care, where early detection can lead to timely interventions, improved outcomes, and reduced burden on tertiary care facilities,' Prof Yeong says in a statement to LifestyleTech. Prof Anand says AI is ubiquitous and its impact is now visible in all sectors of people's personal and professional lives. 'The government has been swift to recognise its potential and been proactive in the early adoption of various innovative AI-driven programmes,' he adds. He also believes social media has helped to normalise the broad concept of AI that 'it seems less daunting and more acceptable' to most people. He adds there is also a growing body of scientific evidence pointing towards AI improving diagnostics accuracy and enhancing the delivery of precision and personalised medical care: 'Collectively, this may have contributed to the wider acceptance,' he says. Dealing with data Despite its potential, the use of AI in disease detection still comes with some limitations that need to be addressed, says Prof Yeong. AI should remain a support tool, while clinicians must continue to play the central role in decision-making. — Prof Yeong Chai Hong 'One major concern is algorithmic bias. Many AI models are trained on datasets from specific populations, which may not generalise well to Malaysia's diverse demographic landscape without proper local validation,' she explains. She also warns of the risk of over-reliance on AI outputs, which could compromise clinical judgment if not carefully managed. 'AI should remain a support tool, while clinicians must continue to play the central role in decision-making. This ensures patient safety and maintains professional accountability,' she says. Another key challenge lies in data governance. Prof Yeong stresses that the safe, ethical, and transparent use of patient data requires strong regulatory frameworks to protect privacy, ensure security, and build public trust in AI-powered healthcare systems. To ensure responsible and ethical use of AI in the public health sector, she calls for a multi-faceted approach underpinned by clear regulatory oversight and well-defined standards. 'Authorities such as the Health Ministry should establish national guidelines to govern the validation, certification, and post-deployment monitoring of AI tools in clinical settings,' she says. She adds that robust measures are needed to protect data privacy and promote transparency. 'This includes building secure digital infrastructures and ensuring that AI models are developed, trained, and tested with full transparency especially regarding the origin and representativeness of the datasets used.' She also highlights the need for continuous monitoring. 'AI tools must be regularly assessed and updated to ensure they remain accurate in real-world conditions, are properly calibrated, and do not produce unequal outcomes across different patient groups especially in today's rapidly evolving healthcare landscape.' While AI can be scaled and deployed in rural areas to assist clinic staff without a radiologist or doctor on-site, Prof Anand points out that strong communication networks are essential for it to work effectively. 'The cost of installing the software, along with maintaining and upgrading server networks – such as 5G infrastructure – can be a limiting factor,' he adds. Dzulkefly has said in the Bernama report that the cost of deploying AI lung screening at the selected government clinics is relatively modest – just RM70,000 – and worth the investment for the benefits of early disease detection. 'Cautiously hopeful' As the founding president of the non-governmental organisation Lung Cancer Network Malaysia (LCNM), Prof Anand has been a key advocate for the use of AI in lung cancer screening. In 2021, LCNM launched a free screening initiative using AI-enhanced chest X-rays at health clinics across the Klang Valley, reaching over 10,000 participants. 'I am excited and cautiously hopeful with the more widespread adoption of AI screening,' he shares. Due to high disease burden and poor outcomes due to most cases being detected at the late stage, he says the time is now ripe for a national level lung screening programme. He adds that other countries like the United Kingdom initiated a national level lung screening programme back in 2019, while Australia is about to start their initiative in July. Ultimately, Prof Anand explains that screening is not a one-off test but part of a longer process that involves follow-up scans, biopsies, and treatment – requiring proper funding and workforce planning. 'There must be a well coordinated pathway for anyone with an abnormal finding on an AI-enabled chest X-ray to be followed up and quickly further investigated,' he adds. For AI tools to be integrated effectively into public healthcare, Prof Yeong says digital infrastructure at hospitals, clinics and screening centres must be strengthened. 'This includes expanding electronic health record (EHR) systems, securing medical data storage and improving network connectivity, particularly in rural and underserved areas where digital access may be limited,' she adds. There is also a need to provide healthcare professionals with digital literacy training and essential knowledge in data science. She also says there should be a structured pathway to expand and scale up successful pilot projects into 'sustainable, nationwide AI-powered programmes'. Beyond health screenings The potential for AI-driven solutions in Malaysia's public sector is vast, according to Prof Yeong. Beyond screening, she sees AI playing a significant role in patient management with tools like AskCPG. 'It can help streamline the implementation of national Clinical Practice Guidelines (CPGs) and optimise healthcare workflows by providing real-time recommendations based on patient data,' she adds. For hospital operations, she says that AI can also help to optimise administrative workflows by predicting patient volumes, managing bed occupancy and even automating appointment scheduling. 'Beyond clinical care, AI is increasingly used in drug discovery and clinical trials. It can optimise drug design tailored to specific populations or individuals, accelerate the identification of new drug candidates, and match patients to appropriate clinical trials based on eligibility criteria,' she adds. Prof Anand also sees the potential for AI to shape the future of health screenings in Malaysia. 'AI has the potential to sift through voluminous data very quickly and will pave the way for precision diagnostics and personalised treatments in the future,' he says, adding that there's the possibility of AI predicting and spotting early warning signs on a chest X-ray or CT scan – even before a tumour fully forms – allowing doctors to closely monitor high-risk patients and take action much earlier. While early intervention can significantly improve a patient's chances of survival, recovery also depends on the individual's own commitment to their health. Prof Anand says the man in his 60s who was diagnosed with lung cancer – through the AI-assisted screening last year – still requires regular follow-ups for the next three to five years. 'He completed his post-surgery adjuvant chemotherapy (as per international protocol) and thankfully remains well and cancer-free. His previously elevated tumour marker levels are now normalising. He has also quit smoking!'
New Straits Times
5 hours ago
- New Straits Times
Forensic crisis in Malaysia: Delays jeopardise justice system
KUALA LUMPUR: Malaysia is grappling with a critical shortage of forensic experts, particularly in pathology and anthropology, raising concerns over delays in criminal investigations and the integrity of the legal system. There are currently only 31 registered forensic pathologists in the country under the National Specialist Register. This equates to a ratio of one forensic expert for every 1.1 million Malaysians, based on the 2024 population of 34.1 million. Law Enforcement and Investigation Association chairman Arie Dwi Andika, said the shortage is causing delays in conducting autopsies for certain cases. "Post-mortem examinations can only be carried out at government hospitals. If conducted in private hospitals, they must be performed by specialists registered under Section 330 of the Criminal Procedure Code," he said. He said that the number of government forensic specialists is inconsistent and cannot meet the demand, especially for serious cases such as suspected suicides. "Because of this, for certain forensic cases — especially serious ones such as suicides — it takes a long time as we have to wait for the availability of a qualified officer." "As a result, there are forensic cases where the findings cannot be obtained immediately — either because the results are not yet ready, or sometimes because there is no officer available to be assigned to the case," he told BH. Arie emphasised that post-mortems cannot be rushed, as doing so risks compromising the findings. "Conducting a post-mortem depends on the staff on duty. One officer may be able to handle two or three bodies a day." "In emergencies such as natural disasters, forensic specialists from other hospitals will assist — but this all depends on how the hospital's schedule is arranged," he added. He said that strict procedures must be followed to maintain the quality of autopsy results. "This is not like treating an outpatient who comes in with a fever. The post-mortem process involves multiple steps and must be conducted thoroughly." He outlined five key stages: determining the cause of death, identifying the body, analysing biological evidence, forensic entomology to confirm time of death, and final body management. "This issue is not about how many bodies we can process in a day — all relevant aspects must be considered." "We ask the public to understand and leave this work to the hospital. At the same time, the hospital must also explain to the public the realities of medical forensics." "Clear communication is important so that the public does not misunderstand why the post-mortem process takes time," he said.
